BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Centre for HIV Strategic Information - ECPv5.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Centre for HIV Strategic Information
X-ORIGINAL-URL:https://www.hivevaluation.org
X-WR-CALDESC:Events for Centre for HIV Strategic Information
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210614T090000
DTEND;TZID=UTC:20210618T130000
DTSTAMP:20260629T014103
CREATED:20210325T183536Z
LAST-MODIFIED:20220519T085232Z
UID:1501-1623661200-1624021200@www.hivevaluation.org
SUMMARY:Data-driven HIV programming to reach HIV epidemic control
DESCRIPTION:Learning Objectives \nThis training workshop will focus on data-driven strategies that enable to optimize HIV interventions and achieve progress towards HIV epidemic control in diverse settings and population groups. \nNew testing and treatment targets that UNAIDS proposed for 2025 adopt the more ambitious 95% objectives: 95% of people living with HIV need to be diagnosed\, 95% of diagnosed should receive treatment for HIV and 95% of those on treatment should be virally suppressed.  In addition\, 95% of people at risk of HIV infection should use appropriate\, prioritized and effective combination prevention options. Effective HIV prevention requires a granular combination approach that is differentiated according to location\, population group and risk of HIV acquisition. \nTo achieve HIV epidemic control\, it is essential to improve programme quality. \nThis course will outline methods that can be used to improve quality of HIV services by identifying critical bottlenecks at different levels of the system\, and identifying and replicating best practices. \nPresentations will outline HIV interventions that need to be prioritized and scaled-up with fidelity\, depending on the epidemic context. These include customized HIV testing such as index testing\, partner notification and HIV self-testing\, pre-exposure prophylaxis\, managed linkage from testing to HIV care and treatment\, and intensified efforts to find those that are missing clinical appointments and/or are lost from HIV treatment.  As countries achieve 90/90/90 and embark on 95/95/95 targets\, there needs to be a shift from case finding to maintaining viral suppression among PLHIV on treatment. Robust patient-level information systems are critical in ensuring there is appropriate action at the site level to address treatment interruptions and lack of viral load suppression among patients. Presentations will describe the US CDC Data to Care strategy that uses HIV surveillance data to identify people who have not been linked to HIV care\, disengaged from care or are not virally suppressed. \nSpecific surveillance activities relevant for epidemic control include HIV case finding\, outbreak detection through surveillance of recent HIV infection and use of age\, sex and key population disaggregated data to identify programmatic gaps. \n  \nCourse objectives are to:  \n\nDescribe a concept of HIV epidemic control and its programmatic elements\nIllustrate data sources and approaches that can be used in quality assurance and improvement of HIV services (root cause analysis\, Site Improvement Through Monitoring System visits\, PDSA\, etc) with examples of HIV testing\, viral load testing and HIV treatment\nHighlight effective HIV case finding approaches\, including index testing and partner notification\, HIV self-testing\, mapping HIV transmission hotspots and mobile testing services\nProvide updates on the use of PrEP in various population groups\nDescribe best practices for incorporating testing for recent HIV infection in case-based surveillance and case finding. and use of recency data\nOutline interventions to engage heterosexual men in services across the HIV continuum of care cascade\nDescribe strategies to identify individuals with newly diagnosed HIV infection and those previously diagnosed with HIV who have either failed to engage in care or who have disengaged from care and treatment and link them to ART clinical services\n\nAn important part of the course is group/individual work. Participants may choose among the following topics: \n\nData quality assessment and improvement\nService quality assessment and improvement\nAssessment of current HIV testing modalities and their effectiveness in terms of yield and positivity\, and development of a proposal for more effective HIV testing services\nDevelop a plan and an evaluation to either link newly diagnosed patients to care services or to re-engage those who have started and subsequently stopped ART\n\nParticipants are encouraged to work on plans/ proposals which they can later on use in their countries. The results of this work will be presented on the final day of the course. \n  \nTeaching Methods \nThe course consists of lectures\, exercises and case studies. \nParticipants will have opportunities to share their own country-specific experiences and challenges encountered in work. \nThe course fee is 800 USD and includes all presentations and course materials. \n  \nLecturers \nProfessor George W. Rutherford\, MD\, Institute for Global Health Sciences\, University of California\, San Francisco\, USA \nAssociate professor Ivana Bozicevic\, MD\, DrPH\, WHO Collaborating Centre for HIV Strategic Information\, School of Medicine\, University of Zagreb\, Croatia \nZoran Dominkovic\, WHO Collaborating Centre for HIV Strategic Information\, School of Medicine\, University of Zagreb\, Croatia \nJurja Ivana Adamsky\, MD\, WHO Collaborating Centre for HIV Strategic Information\, School of Medicine\, University of Zagreb\, Zagreb\, Croatia \n  \nCourse programme: \n\n\n\n  \n14 June 2021\n  \n \n\n\n9.00-9.30\nWelcome and Introductions\n\n\n9.30-10.10 \n  \n \nDefinitions of and metrics for HIV epidemic control  \nIndicators for sustained epidemic control \n\n\n10.10-10.50\nEssential programmatic elements for reaching 95-95-95 targets\n\n\n10.50-11.00\nBreak \n\n\n11.00-11.40\nOverview of present country experiences and plans in achieving HIV epidemic control  \n\n\n11.40-12.20\nDiscussion: Key challenges in progress towards epidemic control in the participating countries \n\n\n\n Break\n\n\n15.00 -15.40\nUse of HIV case-based surveillance and patient monitoring data to enhance HIV control efforts\n\n\n15.40-16.20\n Data quality assessment: example of ART and viral load testing data \n\n\n  \n15 June 2021\n\n\n\n9.00-9.45\nModels of quality assurance and improvement of HIV services (root cause analysis\, Site Improvement Through Monitoring System visits\, PDSA\, etc)\n\n\n9.45-10.30\nCase study: Quality improvement of HIV testing services (index client testing and partner notification)\n\n\n10.30-10.45\nBreak\n\n\n10.45-11.30\nUsing surveillance and programme data to determine quality of HIV services for key populations\n\n\n11.30-12.15\nExercise: Using data to improve quality of services for key populations \nFeedback on the exercise \n\n\n12.15-15.00\nBreak\n\n\n\n\n\n\n15.00-15.40\nUse of HIV care cascades to improve performance at the sub-national and facility level \n\n\n15.40-16.30\nIdentifying targets and implementing improvements  \nExample: Using quality improvement methods to improve ART management and virologic suppression\n\n\n  \n16 June 2021\n\n\n\n9.00-10.00\nSelecting a strategic mix of HIV testing modalities to improve testing coverage and yield\n\n\n10.00-10.50\n Models of implementation and evaluation of HIV self-testing\n\n\n10.50-11.00\n  Break\n\n\n11.00-11.40\nMonitoring gaps in „Test and Treat”: Lost to follow up and treatment interruptions\n\n\n11.40-12.10\nDiscussion: Monitoring lost-to-follow up from HIV treatment in the participating countries  \n\n\n12.10-12.30\nIntroduction to group/individual work  \n\n\n12.30-15.00\nBreak\n\n\n15.00-15.40\nInterventions to re-engage patients in ART care \nUS CDC Data to Care (D2C) Strategy\n\n\n15.40-16.30\nGroup/ individual work supported by facilitators\n\n\n\n  \n\n\n\n  \n17 June 2021\n  \n \n\n\n9.00-9.40\nPre-exposure prophylaxis (PrEP): Implementation and evaluation indicators \n\n\n9.40-10.20\nExercise: PrEP\n\n\n10.20-10.30\nBreak\n\n\n10.30-11.10\nOptimising PrEP delivery to needs of different population groups \n\n\n11.10-11.45\nDiscussion: Differentiated HIV prevention and treatment delivery in the time of COVID-19\n\n\n11.45-12.30\nEngaging heterosexual men in services across the HIV continuum of care cascade \n\n\n12.30-15.00\nBreak \n\n\n15.00-15.40\nIncorporating HIV recency testing in routine HIV testing services \n\n\n15.40-16.00\nUsing HIV recency data to make an impact \n\n\n16.00-16.30\nGroup/ individual work supported by facilitators\n\n\n  \n18 June 2021\n  \n \n\n\n9.00-10.20\nPresentations of group/ individual work\n\n\n10.20-10.40\nBreak\n\n\n10.40-12.00\nPresentations of group/ individual work\n\n\n12.00-12.30\nEvaluations and closure\n\n\n\n  \n
URL:https://www.hivevaluation.org/training-course/data-driven-hiv-programming-to-reach-hiv-epidemic-control-14-18-june-2021/
LOCATION:Online Training Course
END:VEVENT
END:VCALENDAR